Tissue and cell-type identity lie at the core of human physiology and disease. Understanding the genetic underpinnings of complex tissues and individual cell lineages is crucial for developing improved diagnostics and therapeutics. We present genome-wide functional interaction networks for 144 human tissues and cell types developed using a data-driven Bayesian methodology that integrates thousands of diverse experiments spanning tissue and disease states. Tissue-specific networks predict lineage-specific responses to perturbation, identify the changing functional roles of genes across tissues and illuminate relationships among diseases. We introduce NetWAS, which combines genes with nominally significant genome-wide association study (GWAS) P values and tissuespecific networks to identify disease-gene associations more accurately than GWAS alone. Our webserver, GIANT, provides an interface to human tissue networks through multi-gene queries, network visualization, analysis tools including NetWAS and downloadable networks. GIANT enables systematic exploration of the landscape of interacting genes that shape specialized cellular functions across more than a hundred human tissues and cell types.
The precise actions of genes are frequently dependent on their tissue context, and human diseases result from the disordered interplay of tissue-and cell lineage-specific processes [1] [2] [3] [4] . These factors combine to make the understanding of tissue-specific gene functions, disease pathophysiology and gene-disease associations particularly challenging. Projects such as the Encyclopedia of DNA Elements (ENCODE) 5 and The Cancer Genome Atlas (TCGA) 6 provide comprehensive genomic profiles for cell lines and cancers, but the challenge of understanding human tissues and cell lineages in the multicellular context of a whole organism remains 7 . Integrative methods that infer functional gene interaction networks can capture the interplay of pathways, but existing networks lack tissue specificity 8 .
Although direct assay of tissue-specific features remains infeasible in many normal human tissues, computational methods can infer these features from large data compendia. We recently found that even samples measuring mixed cell lineages contain extractable information related to lineage-specific expression 9 . In addition to tissue specificity, we [10] [11] [12] [13] and others [14] [15] [16] [17] have shown that heterogeneous genomic data contain functional information, for example, of gene expression regulation by protein-DNA, protein-RNA, protein-protein and metabolite-protein interactions. Here we develop and evaluate methods that simultaneously extract functional and tissue or cell-type signals to construct accurate maps of both where and how proteins act.
We build genome-scale functional maps of human tissues by integrating a collection of data sets covering thousands of experiments contained in more than 14,000 distinct publications. To integrate these data, we automatically assess each data set for its relevance to each of 144 tissue-and cell lineage-specific functional contexts. The resulting functional maps provide a detailed portrait of protein function and interactions in specific human tissues and cell lineages ranging from B lymphocytes to the renal glomerulus and the whole brain. This approach allows us to profile the specialized function of genes in a high-throughput manner, even in tissues and cell lineages for which no or few tissue-specific data exist.
In contrast with tissue-naive networks, which assume that the function of genes remains constant across tissues 8 , these maps can answer biological questions that are specific to a single gene in a single tissue. For example, we use these maps for the gene IL1B (encoding interleukin (IL)-1β) in the blood vessel network, where it has a key role in inflammation 18 , to predict lineage-specific responses to IL-1β stimulation, which we experimentally confirm. Examination of parallel networks shows changes in gene and pathway functions and Understanding multicellular function and disease with human tissue-specific networks a n a ly s i s npg a n a ly s i s interactions across tissues, identifying tissue-specific rewiring. We demonstrate that several tissue-specific functions of LEF1, encoding the multifunctional lymphoid enhancer-binding factor 1, are evident from the way its connectivity changes in distinct tissues.
Tissue-specific networks provide a new means to generate hypotheses related to the molecular basis of human disease. We developed an approach, termed network-wide association study (NetWAS) . In NetWAS, the statistical associations from a standard GWAS 19 guide the analysis of functional networks. This reprioritization method is driven by discovery and does not depend on prior disease knowledge. NetWAS, in conjunction with tissue-specific networks, effectively reprioritizes statistical associations from distinct GWAS to identify disease-associated genes, and tissue-specific NetWAS better identifies genes associated with hypertension than either GWAS or tissue-naive NetWAS.
Our tissue-specific maps are available through the Genome-Scale Integrated Analysis of Networks in Tissues (GIANT) interface, which provides interactive visualization and exploration of tissuespecific networks, including a comparative view that can highlight the tissue-specific rewiring of genes and pathways. GIANT also provides NetWAS analysis for biomedical researchers to reprioritize their gene-based GWAS results in the context of our human tissuespecific networks.
RESULTS
We integrated diverse genome-scale data in a tissue-specific manner to construct 144 human tissue-and cell lineage-specific networks and demonstrated their broad usefulness for generating specific, testable hypotheses, summarizing tissue-specific relationships between diseases and reprioritizing results from genetic association studies (Fig. 1a) . Our findings underscore the importance of considering tissue specificity when integrating heterogeneous data to understand the pathophysiology of common human diseases.
Integrated tissue-specific functional interaction networks
We isolated tissue-relevant signals from data not resolved to a particular cell lineage or tissue using a Bayesian integration that incorporated the hierarchical relationships between tissues. We collected tissue-specific functional interactions for each tissue from known functional relationships and low-throughput tissue-specific gene expression data, and we mapped tissue-specific gene annotations from the Human Protein Reference Database 20 (HPRD) to the BRENDA Tissue Ontology 21 (BTO). We leveraged this hierarchy to increase gene and tissue coverage and to make the interactions consistent with tissue organization (Online Methods). Using these known tissue-specific interactions, we constructed a Bayesian model of tissue-specific functional information from diverse experiments for each of 144 human tissues. Each tissue network represents the tissue-specific posterior probability of a functional relationship between each pair of genes from an ensemble of data covering more than 14,000 publications (Fig. 1a) .
Our approach accurately identified tissue-relevant signals in the compendium (Fig. 1b and Supplementary Table 1) , automatically up-weighting data sets from relevant tissues and prioritizing tissue-relevant signals over other data. According to fivefold crossvalidation, our method outperformed a Bayesian integration limited to only tissue-related data sets identified on the basis of the experimental description (for 62 of 64 tissues; P = 3.2 × 10 −12 ; Supplementary Fig. 1 ). Our approach also substantially increased the number of tissues for which networks could be constructed. Only 64 tissues had sufficient labeled data to construct networks, but we were able to construct networks for 144 tissues by extracting tissuespecific information from hundreds of data sets. For example, our method constructed a network for the dentate gyrus (a tissue with limited data) by taking advantage of curated dentate gyrus-specific knowledge to extract relevant signals from those for other tissues and cell types in the nervous system. Networks for tissues with no or a very limited amount of data had accuracies comparable to those for tissues with abundant tissue-specific data (Supplementary Fig. 1 ). Our approach generated diverse networks that reflect the tissue-specific connectivity of genes and pathways (Supplementary Table 2 ).
Tissue-specific networks predict IL-1b response Our networks provided experimentally testable hypotheses about tissue-specific gene function and responses to pathway perturbations. We examined and experimentally verified the tissue-specific molecular response of blood vessel cells to stimulation by IL-1β (IL1B), a proinflammatory cytokine. We anticipated that the genes most tightly connected to IL1B in the blood vessel network would be among those responding to IL-1β stimulation in blood vessel cells (Fig. 2a) . We tested this hypothesis by profiling the gene expression of human aortic smooth muscle cells (HASMCs; the predominant cell type in blood vessels) stimulated with IL-1β. Examination of the genes whose expression was significantly upregulated at 2 h after stimulation showed that 18 of the 20 IL1B network neighbors were among the top 500 most upregulated genes in the experiment (P = 2.07 × 10 −23 ; Fig. 2b) . The blood vessel network was the most accurate tissue network in predicting this experimental outcome; none of the other 143 tissue-specific networks or the tissue-naive network performed as well when evaluated by each network's ability to predict the result of IL-1β stimulation on the cells (Fig. 2a) . Nine of the top 20 highestedge weight neighbors of IL1B in the blood vessel network were not top neighbors in the tissue-naive network, and each has a key vasculaturespecific role (Supplementary Table 3 and Supplementary Note). Networks of other cardiovascular system tissues also captured IL-1β response better than the tissue-naive network, and this was consistent across a range of thresholds for top IL1B network neighbors as well as upregulated genes in the experiment (Supplementary Fig. 2b,c) .
We also evaluated nine additional publicly available data sets that used modern genome-wide platforms to measure cellular response to IL-1β stimulation in a diverse set of tissues. In all ten experiments, the appropriate tissue network identified a set of genes that significantly responded to IL-1β, and randomly selected control sets of genes did not show a significant response to treatment (Supplementary Fig. 3 ).
Tissue-specific network rewiring of multifunctional genes Complex multicellular organisms have multifunctional genes that participate in distinct cellular processes according to developmental and anatomical context. For example, developmental programs are known to be controlled by broadly expressed transcription factors that, in specific combinations, regulate cell type-specific gene expression 5, 22, 23 and have the potential to force cell lineage conversions 24, 25 . Multifunctional genes have also been implicated in pleiotropic disease phenotypes 26, 27 . Such effects are likely to arise when a gene is 'rewired' to associate with different functional partners in different tissues. Our genome-wide functional network maps of human tissues could potentially delineate the tissue-specific wiring of multifunctional genes.
We focused on the transcription factor LEF1, which has a key role in mediating the tissue-specific response to Wnt signaling 28 , a fundamental and highly conserved pathway known to elicit diverse cell type-specific developmental responses 29 . Because very little is known about the activity of LEF1 in human tissues, we probed the npg a n a ly s i s tissue-specific functional role of this transcription factor by examining the neighbors of LEF1 across different networks (Fig. 3a shows neighbors in B lymphocytes, hypothalamus, osteoblasts and trachea; Supplementary Fig. 4 shows a detailed view of LEF1 in the B-lymphocyte network). Analysis of LEF1 network partners (Online Methods) showed that, in 12 tissues, LEF1 was significantly associated with processes relevant to each tissue (area under the receiver operating characteristic curve (AUC) ≥ 0.8; Fig. 3b) , reflecting highly accurate representation of tissue-specific wiring of LEF1.
In addition to recapitulating current knowledge (represented by solid blue edges in Fig. 3b) , we identified several new associations between LEF1 and tissue-specific processes in humans that have b Alimentary canal (10) Cardiovascular system (7) Connective tissue (7) Endocrine gland (16) Excretory gland (7) Hematopoietic system (21) Integument (12) Muscular system (5) Nervous system (29) Reproductive system (16) Respiratory system (4) Sense organ (8) Skeletal system (7) Urinary system (5) -1 0 Tissue-relevant data set weighting (z score) (3) We demonstrate the capabilities of the networks by experimentally validating the gene connectivity scores (top), demonstrating that they identify disease associations (middle) and reprioritizing GWAS results (bottom). (b) Bayesian integration using tissuespecific knowledge automatically identifies and weights tissue-relevant data sets. We validate our approach by evaluating the weights in a set of data sets with clear tissue specificity. We calculate a z score for each tissue that measures how much the 'relevant' data sets are up-weighted relative to all data sets in the compendium for that tissue. Plotted here per organ system (y axis) is the distribution of z scores (x axis) of tissues within that system in the form of a box plot. The thick line within each box indicates the median tissue z score for that system; the lower and upper ends of the box indicate the first and third quartiles of the distribution; and the extended lines on either side denote the limits of the distribution, with the outliers (dots) further away. Beyond automatically identifying relevant data sets, our method of automatic weighting constructed higher-quality networks than an identical approach limited to only curation-identified tissue-relevant data sets (supplementary Fig. 1 ). npg a n a ly s i s experimental support in model organisms (represented by dotted red edges in Fig. 3b ). As for the four tissues in Figure 3a , we highlighted predicted functional associations of LEF1 in B lymphocytes, hypothalamus, osteoblasts and trachea (red, orange, green and purple, respectively, in Fig. 3b ). The role of Lef1 in B cell activation has already been characterized in mouse 30, 31 ; further, LEF1 has been strongly linked to chronic lymphocytic leukemia (CLL) [32] [33] [34] . Lef1-mediated Wnt signaling has been shown to be critical for hypothalamic neurogenesis in zebrafish 35, 36 . Numerous studies point to a pivotal role for LEF1 in osteoblast proliferation, maturation, function and regeneration [37] [38] [39] and to its potential involvement in bone disease 40, 41 . Finally, several animal models support a clear association of LEF1 with the development of submucosal glands [42] [43] [44] , which are epithelial secretory structures in the human tracheobronchial airways, involved in hypersecretory lung diseases such as asthma, chronic bronchitis and cystic fibrosis 45 . Thus, tissue-specific networks can unravel the distinct functions of multifunctional genes such as LEF1 and provide opportunities to probe the tissue-specific pleiotropic effects of disease-associated mutations.
Tissue networks can capture disease-disease associations
Most human diseases are syndromes with complex origins and manifestations in multiple tissues 3, 4, 26 . Diseases with common causative pathways or that are connected through crosstalk between pathways are expected to exhibit high levels of functional association in their relevant tissues 26 . We used the tissue-specific networks to quantify molecular interactions between diseases to derive a map of tissuespecific disease relationships. These were data-driven maps discovered from tissue-specific functional associations inferred from an integration of high-throughput data, making them relatively unbiased with respect to prior knowledge of disease associations. Here we focused on Parkinson's disease, a neurodegenerative disorder caused by progressive neuronal loss in the substantia nigra and subsequent reduction in dopamine production 46 . We created a functional disease map of Parkinson's disease based on the substantia nigra network (Fig. 4) . Several documented disease associations were observed in the disease map: for example, Parkinson's disease was connected to 'neurodegenerative disease' and 'basal ganglion disease' , classes of disease that include Parkinson's disease. The disease map also contained more subtle connections. For instance, Parkinson's disease was strongly connected to both lung and reproductive organ cancers, likely through the ubiquitin-protein ligase gene PARK2, which has been implicated in Parkinson's disease as well as brain, colorectal, lung and ovarian cancers 47, 48 . We observed additional undocumented connections to thyroid cancer, driven by functional interactions involving the Parkinson's disease-associated genes PARK2, PARK7 and HTRA2. A blinded literature evaluation showed that this disease map was significantly enriched (Fisher's exact test, P = 0.001228) for associations strongly supported by the literature as compared to a control set of associations (Supplementary Fig. 5 ). Thus, modeling complex diseases in humans using tissue-specific networks provided several insights into disease genetics and crosstalk and highlighted avenues for the discovery of new molecular disease associations. We generated additional disease maps for Alzheimer's disease, glomerulonephritis and glycogen metabolism disorder (Supplementary Fig. 6 ).
Tissue networks are tools for data-driven analysis of GWAS
In the last decade, quantitative genetics-particularly GWAS-has emerged as a powerful approach to catalog heritable and de novo sequence variation associated with a wide range of human traits and diseases 49 . However, owing to the lack of statistical power to detect low-frequency mutations, small genetic effects and epistatic interactions, GWAS findings usually only account for a small proportion of the observed heritability 50 . Because most complex diseases have tissue-specific origins and manifestations, we hypothesized that tissue-specific networks could complement GWAS data in discovering disease-gene associations. Top GWAS hits, even those below a reasonable genome-wide significance cutoff, should be enriched with relevant (even 'real' , causal) genes. Consequently, by identifying the functional signatures associated with these top genes in the appropriate tissue-specific networks, we can further enrich for phenotype-associated genes in a genome-wide re-ranking of the GWAS results. Thus, we developed the network-wide NetWAS approach consisting of a tissue network classifier that learns the network connectivity patterns associated with the phenotype of interest (using the top GWAS hits) and makes predictions for genes across the genome. The NetWAS approach is discovery driven, as the genes used to identify connectivity patterns are derived from the GWAS itself rather than from potentially biased or limited prior disease knowledge. This attribute allows NetWAS to be applied to any GWAS, even TNFAIP6   TNFAIP2   IER3  CCL2   TNFAIP3   CCL20   CXCL2   PLAUR   BCL2A1   IL8   MCL1   CXCL3   CXCL1   IL7R  IL6   PTGS2   IL1R1   CCL2  IL6  CXCL3  CXCL1  BCL2A1  CCL20  TNFAIP6  PTGS2  TNFAIP3  PLAUR  IL7R  MCL1  IL1R1  IL8  IER3  CXCL2  TNFAIP2  SERPINE1  ZC3H12A GLIPR1 npg a n a ly s i s those probing currently uncharacterized or minimally characterized diseases and phenotypes as well as those for which no associations reached genome-wide significance. We applied the NetWAS strategy to a GWAS of hypertension 51, 52 (Online Methods). Hypertension is a major cardiovascular risk factor and a complex trait involving a large number of genetic variants 53 . We converted SNP-level association statistics into gene-level statistics 19 for each of three recorded phenotypes-diastolic blood pressure (DBP), systolic blood pressure (SBP) and hypertension. We applied support vector machines, using genes with nominally significant P values as positive examples and randomly selected genes as negative examples. Using the tissue-specific network for kidney, a tissue that has a central role in blood pressure control 54 , the approach constructed a classifier that identified tissuespecific network connectivity patterns associated with the phenotype of interest. Genes annotated to hypertension phenotypes in the Online Mendelian Inheritance in Man (OMIM) database 55 were more highly ranked by this classifier than by the initial GWAS (Fig. 5a) . We hypothesized that the distinct endpoints might reflect different aspects of the disease. We evaluated whether combining the three phenotypes using a rank-sum approach resulted in predictions with a stronger association with known hypertension genetics than the individual phenotypes and found that it did. This result was specific to the relevant tissues-when performing the same analysis on all tissue-specific networks, we found that the kidney, heart and liver networks showed stronger performance than the tissue-naive network (Supplementary Fig. 7a ).
In addition to well-documented hypertension-associated genes such as MTHFR and PPARG, NetWAS identified several additional candidates (Supplementary Table 4) . Many lines of evidence in the literature link the top predicted genes to hypertension via mechanistic relationships to known disease genes and pathways or associations with hypertension risk factors. Several such examples are tabulated in Supplementary Table 5 . Using functional annotations from Gene Ontology (GO) to subsequently interpret NetWAS-prioritized genes, we observed that NetWAS-ranked genes were annotated to the GO term 'regulation of blood pressure' at a significantly higher frequency than the top-ranked GWAS genes (Fig. 5b) . Because NetWAS provides a useful reprioritization of the genome in terms of phenotypic and functional association, we explored whether the re-ranking was also helpful in discovering appropriate therapeutics. Using drug target Figure 3 Tissue networks capture tissue-specific functional rewiring. (a) Multi-tissue view of LEF1 retrieved from GIANT, a web interface to our tissue-specific networks that facilitates user-directed analysis of human tissue networks. Using the advanced functionality for comparing functional interactions across tissues, we queried GIANT with the multifunctional gene LEF1 (encoding lymphoid enhancer-binding factor 1) in four tissues: B lymphocytes, hypothalamus, osteoblasts and trachea. The retrieved functional neighbors of LEF1 were indeed notably different across the four networks, leading us to the hypothesis that the tissue networks could recapitulate tissue-specific gene wiring. Edge thickness and color correspond to edge strength (color scale in supplementary Fig. 4). (b) The diverse tissue-specific functional rewiring of LEF1. This bipartite graph of tissues (colored rectangles) and processes (black circles) shows how LEF1 participates in different processes in distinct tissues. For example, in the blood vessel, LEF1 is most closely associated with angiogenesis, but in hypothalamus it is closely associated with hypothalamus development. In addition to displaying prior knowledge about the tissue-specific associations of LEF1 (solid blue edges), the tissue networks also aid in the discovery of several new tissue associations that have experimental support in model organisms (dotted red edges). npg a n a ly s i s data from DrugBank 56 , we found that targets of antihypertensive drugs were significantly enriched among the top genes from NetWAS more than among the top genes from GWAS (Fig. 5c) . We found similar results for drug targets from three other databases (PharmGKB 57 , TTD 58 and CTD 59 ; Supplementary Fig. 7b ).
We evaluated NetWAS on four additional GWAS spanning diverse disease and tissue contexts and found that the approach consistently ranked documented disease-associated genes higher than the GWAS (Supplementary Fig. 8 ). Thus, NetWAS builds from nominally significant associations from GWAS to identify candidates by their connectivity in tissue-specific networks that are valuable for guiding research into disease mechanisms and therapy.
A dynamic, interactive interface for biomedical researchers
To facilitate broad use of these networks by biomedical researchers, we have developed GIANT-a dynamic, interactive web interface. Researchers can query by individual genes or by gene sets of interest to analyze tissue-specific gene functions and interactions. For example, GIANT can provide tissue-specific functional maps and predictions of tissue-specific gene function and disease association. Multitissue view allows for rapid examination of the tissue-specific rewiring of functional connections across diverse tissues (Fig. 3a) . Custom gene set functionality is implemented using the Tribe web service and is integrated into user analyses, such as biological process enrichment and querying by gene set. GIANT also provides a full NetWAS implementation, allowing users to upload gene-based association P values to receive NetWAS association scores. Visualizations in the user-friendly, dynamic web interface are implemented using the D 3 library 60 , which enables use on any modern web browser without plugin installation. In addition to the interface, all of the underlying networks are provided for download, and the full list of input data sets and their sources is available through the webserver.
DISCUSSION
Genes with tissue-specific expression and function have key roles in the physiological processes of complex organisms, and such genes are expected to underlie many human diseases 2, 3 . Recent advances Figure 5 Network reprioritization of hypertension GWAS identifies hypertension-associated genes. Genes ranked using GWAS (gray) and genes reprioritized using NetWAS (brown) were assessed for correspondence to genes known to be associated with hypertension phenotypes, regulatory processes and therapeutics. We compared individual (systolic blood pressure, SBP; diastolic blood pressure, DBP; hypertension, HTN) as well as combined hypertension endpoints. (a) Gene rankings were compared to OMIM-annotated hypertension genes using AUC. The AUC for the tissue-specific NetWAS is consistently higher than that for the original GWAS for all hypertension endpoints. Merging the network-based predictions for the three hypertension-related endpoints into a combined phenotype results in the best performance (AUC = 0.77; original GWAS AUC = 0.62; the dashed line at 0.5 denotes the AUC of a baseline random predictor). (b,c) Gene rankings were also assessed for enrichment of genes involved in the regulation of blood pressure (GO) (b) and targets of antihypertensive drugs (DrugBank) (c). The top NetWAS results were significantly enriched for genes involved in blood pressure regulation as well as for genes that are targets of antihypertensive drugs. Enrichment was calculated as a z score (Online Methods), with higher scores indicating a greater shift from the expected ranking toward the top of the list. In nearly all cases, the NetWAS ranking was both significantly enriched with the respective gene sets (z score > 1.645 ≈ P value < 0.05) and more enriched than in the original GWAS ranking. npg a n a ly s i s now allow for high-throughput discovery of genes expressed in specific lineages in solid tissues 9, 61 . The next challenge is to understand the tissue-specific function of genes. This remains difficult because the precise functions of genes in multicellular organisms such as humans are defined by the context in the cell lineage where the genes are expressed. Tissue-specific interactions are not well characterized because high-throughput interaction measurements are largely infeasible in solid tissues and their cell lineages. For direct studies of human genes, the tools available to assess tissue-specific function are generally confined to cell lines, many of which have diverged phenotypically from normal tissues. Moreover, many low-throughput experiments are highly skewed toward well-studied genes 7, 62 .
We developed a data-driven approach that identifies tissuespecific interactions by integrating heterogeneous publicly available data using a tissue-specific regularized Bayesian framework. Our learned networks complement the tools of modern molecular genetics by more precisely predicting tissue-specific relationships to generate hypotheses about tissue-specific gene action. These lineage-specific networks also effectively connect the roles of genes in cell lineages to common diseases. We leverage this power in NetWAS, which uses GWAS as the starting point for network analysis and provides a way to increase the value of existing GWAS. Other methods 63 that reprioritize GWAS findings using networks are also expected to benefit substantially from tissue-specific networks. Analysis of genetic association data presents a key opportunity to apply tissue-specific networks to understand common human diseases. Because these networks accurately weigh and integrate diverse molecular data, they provide a more complete picture of the relationships between genes, phenotypes and tissues and a clearer understanding of the etiology of complex disease. This is particularly important in the domain of phenome-wide association studies that rely on endpoints gleaned from electronic health records (EHRs) 64 . Tissue-specific networks can provide the necessary gene and tissue context to analyze such data and will help in scaling methods to the repositories that we expect to see in the coming era of widespread EHR and genetic data.
Healthy and disease states in humans are the result of the interplay of genes within specific cell lineages and tissues, modulated by environmental exposures. Many of the key challenges in medicine involve tissue specificity. For example, identifying off-target effects for therapeutics requires an understanding of the therapeutics' effect not just in the target tissue but also in all tissues. By disentangling the functions of genes in specific tissues, integrated tissue-specific networks learned from large data compendia present a means to address these challenges.
URLs. GIANT, a web portal for tissue-specific functional networks, http://giant.princeton.edu/; Sleipnir, an open source library for functional genomics, http://libsleipnir.bitbucket.org/; Tribe, a web service that provides cross-server analysis of gene sets, http://tribe. greenelab.com/.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene expression measurements of HASMCs with and without IL-1β stimulation are available in the Gene Expression Omnibus (GEO) database under accession GSE59671.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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AUTHOR COnTRIBUTIOnS
ONLINE METhODS
Data download and processing. We collected and integrated 987 genomescale data sets encompassing approximately 38,000 conditions from an estimated 14,000 publications including both expression and interaction measurements. We downloaded interaction data from BioGRID 65 , IntAct 66 , MINT 67 and MIPS 68 . BioGRID edges were discretized into five bins, labeled 0 to 4, where the bin number reflected the number of experiments supporting the interaction. For the remaining databases, edges were discretized into the presence or absence of an interaction.
Predicting transcriptional regulation on the basis of DNA sequence is a major challenge in understanding transcription at a systems level. To estimate shared transcription factor regulation, binding motifs were downloaded from JASPAR 69 . Genes were scored for the presence of transcription factor binding sites using the MEME software suite 70 . FIMO 71 was used to scan for each transcription factor profile within the 1-kb sequence upstream of each gene 72 . Motif matches were treated as binary scores (present if P < 0.001). The final score for each gene pair was obtained by calculating the Pearson correlation between the motif association vectors for the genes.
Chemical and genetic perturbation (c2:CGP) and microRNA target (c3:MIR) profiles were downloaded from the Molecular Signatures Database (MSigDB 73 ). Each gene pair's score was the sum of shared profiles weighted by the specificity of each profile (1/len(genes)). The resulting scores were converted to z scores and discretized into bins ((−infinity, −1. We downloaded all gene expression data sets from NCBI's Gene Expression Omnibus 74 (GEO) and collapsed duplicate samples. GEO contains 980 human data sets representing 20,868 conditions. Genes with more than 30% of values missing were removed, and remaining missing values were imputed using ten neighbors 75 . Non-log-transformed data sets were log transformed. Expression measurements were summarized to Entrez 76 Hierarchically aware knowledgebase construction via ontological pruning with functional knowledge transfer. Functional knowledge extraction. We constructed a tissue-naive functional relationship gold standard from a set of 564 expert-selected GO biological process terms and experimentally derived gene annotations (GO evidence codes: EXP, IDA, IPI, IMP, IGI and IEP). Curators identified processes testable through specific molecular experiments (Supplementary Table 6 ). Pairs of genes that were co-annotated to expert-selected terms after propagation were treated as positive (i.e., functionally related) examples. Gene pairs not co-annotated to any of these terms were considered as negative examples, except in the following cases: (i) if two genes were annotated to two different GO terms with a significant number of shared genes (hypergeometric P value < 0.05) and (ii) if two genes were co-annotated to a set of 'negative' GO terms that defined minimal relatedness 77 . Gene pairs that met either condition were excluded from the set of negative examples and treated as neither related nor unrelated.
Functional knowledge transfer. To increase the coverage of functional interactions, we transferred experimentally confirmed mouse GO annotations to human functional analogs identified by FKT 13 , a high-specificity annotation transfer method, for the 520 GO terms with mouse annotations. This resulted in a tissue-naive gold standard of 604,038 functionally related gene pairs (positive examples) and 12,425,713 potentially unrelated pairs (negative examples).
Ontology pruning. Gene-to-tissue annotations were obtained from the Human Protein Reference Database (HPRD) 20 . HPRD tissues were mapped to the BRENDA Tissue Ontology 21 (BTO) using direct matching where possible and manual curation where direct matches were unavailable (Supplementary Table 7 ). Tissues with fewer than ten directly annotated genes were pruned as non-informative from a molecular standpoint (for example, BTO:0001493, trunk). Pruning resulted in an ontology containing functional, as opposed to structural, divisions of tissues and cell lineages (Supplementary Table 8) .
We defined 'tissue categories' from generic BRENDA terms, for example, nervous system, to categorize tissues into organ systems for evaluation and analysis. For each tissue, we termed the set T as those genes directly annotated to that tissue or any of its descendants in the ontology. We used tissue categories to define unrelated tissues (those not associated with the same category as the tissue of interest). We defined T′ for each tissue as genes specifically annotated to unrelated tissues.
Annotation of ubiquitously expressed genes. Genes ubiquitously expressed across tissues frequently carry out core biological processes and interact with tissue-specific genes to perform specialized functions 78 . We identified ubiquitous genes from a multi-tissue RNA sequencing experiment 79 and added 'widely expressed' genes from a multi-cell line mass spectroscopy experiment 80 , genes for proteins expressed in >75% of the tissues assayed in the human protein atlas 81 and curated 'ubiquitous genes' from HPRD 20 . These 8,475 ubiquitous genes (U) were considered expressed in all tissues and cell types, in addition to the curated tissue-specific genes (T). Sets T and U were made disjoint by retaining only genes in T genes that were not in U.
Integration of tissue-specific and functional knowledge. We combined the curated gene-to-tissue annotations with the tissue-naive functional gold standard to construct a hierarchical tissue-specific knowledgebase. We labeled each gene pair (positive or negative) in the functional relationship standard as specifically coexpressed in a tissue if both genes were tissue specific (T, T) or one was tissue specific and the other was ubiquitous (T, U). Interactions between ubiquitous gene pairs were deemed not tissue specific and were ignored. After labeling specifically coexpressed gene pairs (edges) across all tissues, we considered four classes of edges-C1, C2, C3 and C4-to constitute each tissue standard. Among the four tissue classes, C1 represented tissue-specific functional relationships. To identify tissue-specific relationships, we constructed a specific gold standard for each tissue by labeling edges in C1 as positives and edges in the other classes as negatives. Because C3 is defined on the basis of tissue-expressed genes and C2 and C4 are defined on the basis of non-expressed genes, the number of edges in these classes varied across tissues according to how specific (cell type, tissue, organ or system), well studied (or easily studied) and well curated (literature bias) they are. To construct comparable networks across tissues, we used a negative set composed of equal proportions of edges from C2, C3 and C4. We limited all integrations to the set of 144 tissues (Supplementary Table 8 ) that contained at least ten C1 edges between tissue-specific genes (T-T). This method incorporates the hierarchical relationships of tissues, allowing supervised methods to leverage these relationships. Data integration. We constructed functional networks from genome-scale data by performing a tissue-specific Bayesian integration. We trained one naive Bayesian classifier for each tissue using the tissue-specific standards described above. We also trained a classifier limited to only functional interactions to generate a tissue-naive network. In each case, we constructed a class node, i.e., the presence or absence of a functional relationship between a pair of genes that is conditioned on nodes for each data set. For large-scale genomics data sets, the assumption of conditional independence required for a naive Bayes classifier is often not met, so we calculated and corrected for non-biological conditional dependency 13 .
Each tissue model trained on the hierarchy-aware tissue-specific knowledge was used to make genome-wide predictions by estimating the probability of tissue-specific functional interaction between all pairs of genes. We also estimated the probability of global functional interactions for the tissue-naive where X w is the mean weight of edges between the two disease gene sets, X b is the mean weight of all genome-wide edges incident to either gene set, and s and n are the respective standard deviation and sizes of the distributions.
We generated a bootstrapped null distribution for each disease pair by sampling 10,000 random gene set pairs of the same size and recalculated the above t statistic. With this null distribution, we calculated the final disease association score for each disease pair as follows: where t i,j is the calculated t statistic for a disease pair, and µ and s are the mean and standard deviation of the null distribution. We applied a z-score cutoff of 2.5 to produce the Parkinson's disease map in Figure 4 .
Blinded literature evaluation of the disease association map. To rigorously evaluate these maps, we constructed and shuffled a list of putative associations for Parkinson's disease that combined associations from the disease map with ten randomly selected control associations. We provided this list to a researcher with no previous exposure to our manuscript or results. This researcher categorized disease associations from the literature as 'strong' , indicating there was clear evidence, 'weak' , indicating that there existed co-mentions but that the available evidence was limited, or 'none' , indicating that there were no publications with co-mentions.
Network-based reprioritization of genome-wide association study. We used tissue-specific networks to reprioritize gene candidates associated with hypertension endpoints in a GWAS. We hypothesized that disease-relevant genes would be enriched among the nominally significant genes, which would allow reprioritization through modern machine learning methods. We trained a support vector machine classifier using nominally significant (P < 0.01) genes as positive examples and 10,000 randomly selected non-significant (P ≥ 0.01) genes as negatives. The classifier was constructed using the tissue network specific to kidney, a tissue associated with hypertension 54 , where the features of the classifier were the edge weights of the labeled examples to all the genes in the network. Genes were re-ranked using their distance from the hyperplane, which represented a network-based prioritization of a GWAS, termed NetWAS. We applied NetWAS to a GWAS from the Women's Genome Health Study to identify additional genes involved in hypertension 51 . The study focused on three hypertension-related endpoints: systolic blood pressure, diastolic blood pressure and hypertension diagnosis. To calculate per-gene P values for each endpoint, we used the versatile gene-based association study (VEGAS) system 19 . To generate a combined list across phenotypes, we combined results from each hypertension-related endpoint using summed ranks. Performance was assessed by evaluating the ranking of genes annotated to 'hypertension' in OMIM. We performed functional evaluation by comparing NetWAS results to genes annotated to the term 'regulation of blood pressure' in GO. We performed an analogous calculation for therapeutics with targets of antihypertensive drugs from four different databases: DrugBank, TTD, PharmGKB and CTD.
Evaluation of additional GWAS data. We performed NetWAS on four additional GWAS: C-reactive protein levels (lnCRP) 51 , type 2 diabetes (T2D) 88 , body mass index (BMI) 89 and advanced age-related macular degeneration (advanced AMD) 90 . Publicly available studies were obtained from their respective websites (BMI, advanced AMD) or the database of Genotypes and Phenotypes (dbGaP) 91 (T2D, phs000007-pha000418) . NetWAS was applied as described for the hypertension NetWAS analysis. The relevant OMIM diseases were used to evaluate NetWAS results in relevant tissues.
